-
Article
Concomitant CIS on TURBT does not impact oncological outcomes in patients treated with neoadjuvant or induction chemotherapy followed by radical cystectomy
Cisplatin-based neoadjuvant chemotherapy (NAC) for muscle invasive bladder cancer improves all-cause and cancer specific survival. We aimed to evaluate whether the detection of carcinoma in situ (CIS) at the t...
-
Article
Open AccessAssociation Of Plasma And Urinary Mutant DNA With Clinical Outcomes In Muscle Invasive Bladder Cancer
Muscle Invasive Bladder Cancer (MIBC) has a poor prognosis. Whilst patients can achieve a 6% improvement in overall survival with Neo-Adjuvant Chemotherapy (NAC), many do not respond. Body fluid mutant DNA (mu...
-
Article
Differences in histopathological evaluation of standard lymph node dissections result in differences in nodal count but not in survival
To analyse whether the reported differences in nodal yield at pelvic lymph node dissection (PLND) for bladder cancer, between two hospitals, are reflected in the survival rates.
-
Article
19 Inductiechemotherapie en chirurgie bij klierpositief blaascarcinoom
-
Article
Neoadjuvante chemotherapie bij lokaal gevorderd en/of naar de lymfeklieren gemetastaseerd blaascarcinoom
-
Article
22 Gecombineerde radio- en fluorescentiegeleide schildwachtklierbiopsie bij patiënten met een peniscarcinoom ter vervanging van patentblauw?
-
Article
1 Standaard lymfeklierdissectie bij blaascarcinoom: significante verschillen in het aantal gerapporteerde lymfeklieren